BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//wp-events-plugin.com//7.3.5//EN
TZID:America/Detroit
X-WR-TIMEZONE:America/Detroit
BEGIN:VEVENT
UID:41@amyloidosis.org
DTSTART;TZID=America/Chicago:20260701T180000
DTEND;TZID=America/Chicago:20260701T184500
DTSTAMP:20260602T133955Z
URL:https://amyloidosis.org/events/second-line-options-for-relapsed-refrac
 tory-disease-coh-experience-with-venetoclax-for-al-amyloidosis/
SUMMARY:Second line options for relapsed/refractory disease COH experience 
 with venetoclax for AL Amyloidosis
DESCRIPTION:Webinar Session: Wednesday\, July 1st at 6 PM (ET) Zoom Meeting
 \n\n(These sessions will not be recorded due to patient involvement and HI
 PAA laws)\n\nTo Register HERE\nSecond line options for relapsed/refractor
 y disease COH experience with venetoclax for AL Amyloidosis\nJoin us for a
 n informative session on second-line treatment options for relapsed or ref
 ractory AL amyloidosis\, focusing on venetoclax. Experts will explain how 
 it works\, share City of Hope experience\, and discuss what patients may e
 xpect during therapy. Learn more about your options and connect with other
 s on this journey.\n\nDr. Michael Rosenzweig is Chief of the Division of M
 ultiple Myeloma and Director of the Amyloidosis Program at City of Hope. A
  hematologist-oncologist with expertise in plasma cell disorders\, he care
 s for patients with multiple myeloma\, Waldenström macroglobulinemia\, PO
 EMS syndrome\, and all forms of amyloidosis — AL\, TTR\, AA\, and LECT2.
  He trained at Boston Medical Center and Memorial Sloan Kettering\, and pr
 eviously directed the Amyloid Treatment and Research Program at Boston Uni
 versity.\n\n\n\nSpeaker: Dr. Michael Rosenzweig\, Hematologist-Oncologist\
 n\n\n\n\n
END:VEVENT
BEGIN:VTIMEZONE
TZID:America/Chicago
X-LIC-LOCATION:America/Chicago
BEGIN:DAYLIGHT
DTSTART:20260308T030000
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
END:DAYLIGHT
END:VTIMEZONE
END:VCALENDAR